(603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Repurchasing Shares
Filed with SSE · Stock code 603079 · · 2 pages · Chinese
Summary by 6ix AI
Zhejiang Shengda Bio-pharm Co., Ltd. has announced the progress of its share repurchase plan, detailing the basic situation and updates on the repurchase as of the end of September. The company has repurchased a total of shares, which represents a small percentage of its total share capital, and has provided details on the price range of the repurchased shares. The announcement emphasizes compliance with relevant regulations and the company's commitment to timely information disclosure regarding the repurchase process.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/603079zhejiang-shengda-bio-pharm-co-ltdannouncement-on-progress-in-repurchasing-shares
Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix
Story so far
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
- Announcement on Progress in Opening Dedicated Settlement Account for Cash Management Products Purchased with Raised Funds and Using Idle Raised Funds for Cash Management
- Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
Earlier from Zhejiang Shengda Bio-Pharm
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
- Announcement on Progress in Opening Dedicated Settlement Account for Cash Management Products Purchased with Raised Funds and Using Idle Raised Funds for Cash Management
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Progress in Repurchasing Shares
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
Later from Zhejiang Shengda Bio-Pharm
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash Management
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Expiration of the 1st Lock-up Period and Satisfaction of Unlocking Conditions under the 2024 Employee Stock Ownership Plan
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Key Operating Data for Q3 2026
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Resolutions of the 7th Meeting of the 5th Board of Directors
Follow Zhejiang Shengda Bio-Pharm into a list and get an email when it puts out news.
Follow Zhejiang Shengda Bio-Pharm